Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".
Journal Article (Letter)
The authors of the manuscript "Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population" respond to a letter to the editor.
Full Text
Duke Authors
Cited Authors
- Wittbrodt, ET; Eudicone, JM; Bell, KF; Enhoffer, DM; Latham, K; Green, JB
Published Date
- April 2019
Published In
Volume / Issue
- 25 / 4
Start / End Page
- 171 - 172
PubMed ID
- 30986013
Electronic International Standard Serial Number (EISSN)
- 1936-2692
Language
- eng
Conference Location
- United States